| Typicality: | 0.420 |
| Saliency: | 0.616 |
| during human trials | 12 | temporal |
| in adults | 8 | temporal |
| based on sound scientific evidence | 8 | other |
| vaccine → be shown to be → safe | 106 |
| vaccine → be proven → safe | 93 |
| vaccine → be proven to be → safe | 57 |
| vaccine → be demonstrated to be → safe | 9 |
| vaccine → be proved to be → safe | 7 |
| vaccine → be proved → safe | 6 |
| negative | neutral | positive |
| 0.143 | 0.359 | 0.498 |
| Raw frequency | 278 |
| Normalized frequency | 0.616 |
| Modifier score | 0.483 |
| Perplexity | 16.036 |